<DOC>
	<DOCNO>NCT02032290</DOCNO>
	<brief_summary>The administration drug realize accord European Society Cardiology guideline . All patient pretreated aspirin 300 mg orally , heparin iv maintain activate clotting time &gt; 250 sec , load dose ticagrelor ( 180 mg ) clopidogrel ( 600 mg ) immediately revascularization . The list assignment ticagrelor clopidogrel generate computer accord 1:1 randomization . Primary Percutaneous Coronary Intervention perform accord standard clinical practice use femoral radial artery Judkins approach via six seven French heath insertion . After cross target occlusive Lesion , coronary stenting perform base standard practice . Patients subsequently receive heparin 48 hr , aspirin 100 mg daily , clopidogrel ( 75 mg/day ) ticagrelor ( 90 mg twice daily ) least 12 month . Other adjunctive pharmacotherapy Intensive Care Unit administer accord operator discretion . All patient provide write informed consent enter study . Before procedure 12-leads ECG echocardiogram perform standard practice . Then , pre- , intra- , post-procedure data patient collected database . Investigators aim perform prospective , single-center , investigator-initiated , randomize study compare Adenosine-induced coronary vasodilatation load dose Ticagrelor either Clopidogrel Percutaneous Coronary Intervention . Patients Acute Coronary Syndrome undergo Percutaneous Coronary Intervention enrol study randomize , 1:1 ratio , receive load dose Ticagrelor ( 180 mg ) Clopidogrel ( 600 mg ) . Coronary Flow Reserve record intracoronary Doppler Flow Wire stent implantation procedure baseline 2-minute later adenosine intravenous administration incremental dose 50 , 80 , 110 140 ug/Kg/min 2 minute interval infusion . Coronary Flow Reserve ability myocardium increase blood flow response maximal exercise . Doppler Flow Wire allow measure increase express ratio maximal vasodilation flow rest . Coronary Flow Reserve routinely measure patient Acute Coronary Syndrome , without increase risk adverse event patient neither adjunctive cost National Health System . Furthermore , Plasma concentration Ticagrelor main metabolite ( AR-C124910XX ) measure venous blood collect end procedure . In patient require second Percutaneous Coronary Intervention , example multivessel disease , measure repeat manner .</brief_summary>
	<brief_title>Assessment Coronary Flow Reserve Doppler Flow Wire Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between Loading Dose Ticagrelor Clopidogrel</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patients acute coronary syndrome undergo Percutaneous Coronary Intervention stent implantation ; Patients ≥ 18 ≤ 75 year old . Signed informed consent ; Patients stable angina ; prior myocardial infarction ; prior revascularization ( Percutaneous Coronary Intervention coronary artery bypass graft ) ; Clopidogrel and/or Ticagrelor contraindication ( history intracranial hemorrhage , active pathological bleeding , severe hepatic impairment ) ; major periprocedural complication ; Glomerular filtration rate &lt; 30 ml/min require haemodialysis ; Nonsinus rhythm ; severe chronic obstructive pulmonary disease ; requirement oral anticoagulant ; risk bleed bradycardic event ; Ejection fraction &lt; 45 % ; Cardiogenic shock ; Severe leave ventricular hypertrophy ; severe valvular disease ; indication coronary artery bypass grafting ; diffuse coronary atherosclerosis ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>